Skip to main content
TipRanks
Go Ultimate75% OFF

Compare Palvella Therapeutics (PVLA) vs. Competitors

805 Followers

Comparison Results

Comparison results
NamePriceMarket CapP/E RatioYearly GainAnalyst ConsensusAnalyst Price TargetCompareTop Analysts' Price TargetSmart ScoreFollow
PVLAPalvella Therapeutics$146.58$2.14B-26.6576.73%Strong BuyUnlock the PVLA analyst price target with TipRanks PremiumPVLAUnlock the PVLA top-analyst price target with TipRanks Premium
MNPRMonopar Therapeutics Inc$70.75$479.46M-27.42-12.22%Strong BuyUnlock the MNPR analyst price target with TipRanks PremiumPVLA vs MNPRUnlock the MNPR top-analyst price target with TipRanks Premium
NRIXNurix Therapeutics$14.10$1.56B5.6211.20%Strong BuyUnlock the NRIX analyst price target with TipRanks PremiumPVLA vs NRIXUnlock the NRIX top-analyst price target with TipRanks Premium
TYRATyra Bioscience$19.61$1.35B-7.4322.26%Strong BuyUnlock the TYRA analyst price target with TipRanks PremiumPVLA vs TYRAUnlock the TYRA top-analyst price target with TipRanks Premium

Performance Comparison

-50%-25%0%25%50%75%100%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Performance comparison by fund
TickerCompany NamePriceChange% Change
PVLAPalvella Therapeutics146.5855.0460.13%
MNPRMonopar Therapeutics Inc70.75-12.25-14.76%
NRIXNurix Therapeutics14.10-1.23-8.02%
TYRATyra Bioscience19.61-1.39-6.62%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts